Koen Demyttenaere, MD, PhD

Suicidal Thoughts and Behaviors During College

August 23, 2017

Adolescence carries a high risk for suicidal thoughts and behaviors. This study aimed to identify patterns of suicidal thoughts and behaviors in college students with a prior history of...

Philippe Mortier, Glenn Kiekens, Randy P. Auerbach, et al

Article

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

June 15, 2014

Around 15% of patients with major depressive disorder acknowledge having made a suicide attempt. This post hoc analysis of the data from a previously published study was conducted to...

Koen Demyttenaere, Durisala Desaiah, Joel Raskin, et al

Article

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

December 15, 2011

Read this meta-analysis of studies examining the efficacy of duloxetine for both painful physical symptoms and depressive illness in patients with mild to moderate major depressive disorder.

Susan G. Ball, Durisala Desaiah, Melissa E. Spann, et al

Letter to the Editor

Correction for "'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories"

October 15, 2011

Koen Demyttenaere, Anne Verhaeghen, Nicolas Dantchev, et al

Article

Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis

July 28, 2011

Is satisfaction with taking medication associated with clinical outcome and persistence with treatment? Review results from a study that used item 15 of the Quality of Life Enjoyment and...

Koen Demyttenaere, Elin Heldbo Reines, Sara Larsson Lönn, et al

Original Research

'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories

December 17, 2009

Koen Demyttenaere, Anne Verhaeghen, Nicolas Dantchev, et al

Original Research

Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

February 16, 2009

Koen Demyttenaere, Durisala Desaiah, Claude Petit, et al

Original Research

Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial

November 15, 2007

Stephan Brecht, Christine Courtecuisse, Catherine Debieuvre, et al

Original Research

Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study

July 16, 2007

Daniel Souery, Pierre Oswald, Isabelle Massat, et al

Original Research

What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors?

July 15, 2005

Koen Demyttenaere, Adelin Albert, Patrick Mesters, et al

Article

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

January 8, 2001

Koen Demyttenaere, Paul Enzlin, Walthere Dewe, et al

Article

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

January 8, 2001

Koen Demyttenaere, Paul Enzlin, Walthere Dewe, et al

Suicidal Thoughts and Behaviors During College

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

Correction for "'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories"

Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis

'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories

Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial

Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study

What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors?

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

ELSEWHERE:

FOLLOW US:

Koen Demyttenaere, MD, PhD

Suicidal Thoughts and Behaviors During College

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

Correction for "'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories"

Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis

'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories

Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial

Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study

What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors?

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles